COMP <GO>
CMI vs TMO // REVENUE GROWTH (YOY)
Cummins Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CMI 7
— TMO 8
▲ REVENUE GROWTH (YOY) LEADER: TMO
LAST: $500.09 (-3.46%) • MKT CAP: $71.31B
revenue-growth
-1.30%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
revenue-growth
3.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CMI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CMI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.30% | 41.00% | -15.70 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.50% | 9.30% | +8.20 | CMI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.2x | 30.4x | -15.20 | CMI | /valuation <GO> |
| Free Cash Flow Yield | 3.35% | 2.40% | +0.95 | CMI | /fcf-yield <GO> |
| Operating Margin | 12.00% | 17.40% | -5.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 9.30% | 15.10% | -5.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -1.30% | 3.90% | -5.20 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.48% | 0.24% | +1.24 | CMI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.65 | 4.50 | +0.15 | CMI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.70% | +0.40 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.2 | 59.1 | -22.97 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.94 | +0.11 | CMI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.1x | 36.3x | -15.20 | CMI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $71.31B | $262.22B | -$190.90B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CMI REV | TMO REV | CMI GROSS % | TMO GROSS % | CMI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $33.67B | $44.56B | 25.3% | 44.0% | $2.39B | $6.29B |
| FY 2024 | $34.10B | $42.88B | 24.7% | 44.0% | $279.0M | $7.27B |
| FY 2023 | $34.06B | $42.86B | 44.0% | 44.0% | $2.43B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CMI // BETA 1.05
TMO // BETA 0.94